Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

197 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A population-based assessment of myocarditis after messenger RNA COVID-19 booster vaccination among adult recipients.
Naveed Z, Li J, Naus M, Velásquez García HA, Wilton J, Janjua NZ; Canadian Immunization Research Network Provincial Collaborative Network investigators. Naveed Z, et al. Among authors: janjua nz. Int J Infect Dis. 2023 Jun;131:75-78. doi: 10.1016/j.ijid.2023.03.027. Epub 2023 Mar 24. Int J Infect Dis. 2023. PMID: 36967038 Free PMC article.
Effectiveness of COVID-19 vaccines in people living with HIV in British Columbia and comparisons with a matched HIV-negative cohort: a test-negative design.
Fowokan A, Samji H, Puyat JH, Janjua NZ, Wilton J, Wong J, Grennan T, Chambers C, Kroch A, Costiniuk CT, Cooper CL, Burchell AN, Anis A; COVAXHIV study team. Fowokan A, et al. Among authors: janjua nz. Int J Infect Dis. 2023 Feb;127:162-170. doi: 10.1016/j.ijid.2022.11.035. Epub 2022 Dec 1. Int J Infect Dis. 2023. PMID: 36462571 Free PMC article.
Risk of COVID-19 hospitalization in people living with HIV and HIV-negative individuals and the role of COVID-19 vaccination: A retrospective cohort study.
Puyat JH, Fowokan A, Wilton J, Janjua NZ, Wong J, Grennan T, Chambers C, Kroch A, Costiniuk CT, Cooper CL, Lauscher D, Strong M, Burchell AN, Anis AH, Samji H; COVAXHIV Study Team. Puyat JH, et al. Among authors: janjua nz. Int J Infect Dis. 2023 Oct;135:49-56. doi: 10.1016/j.ijid.2023.06.026. Epub 2023 Jul 5. Int J Infect Dis. 2023. PMID: 37419410 Free article.
Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study.
Hamill V, Wong S, Benselin J, Krajden M, Hayes PC, Mutimer D, Yu A, Dillon JF, Gelson W, Velásquez García HA, Yeung A, Johnson P, Barclay ST, Alvarez M, Toyoda H, Agarwal K, Fraser A, Bartlett S, Aldersley M, Bathgate A, Binka M, Richardson P, Morling JR, Ryder SD, MacDonald D, Hutchinson S, Barnes E, Guha IN, Irving WL, Janjua NZ, Innes H. Hamill V, et al. Among authors: janjua nz. BMJ. 2023 Aug 2;382:e074001. doi: 10.1136/bmj-2022-074001. BMJ. 2023. PMID: 37532284 Free PMC article.
Background rates of adverse events of special interest for COVID-19 vaccines: A multinational Global Vaccine Data Network (GVDN) analysis.
Phillips A, Jiang Y, Walsh D, Andrews N, Artama M, Clothier H, Cullen L, Deng L, Escolano S, Gentile A, Gidding G, Giglio N, Junker T, Huang W, Janjua N, Kwong J, Li J, Nasreen S, Naus M, Naveed Z, Pillsbury A, Stowe J, Vo T, Buttery J, Petousis-Harris H, Black S, Hviid A. Phillips A, et al. Vaccine. 2023 Oct 6;41(42):6227-6238. doi: 10.1016/j.vaccine.2023.08.079. Epub 2023 Sep 5. Vaccine. 2023. PMID: 37673715 Free article.
Treatment of HCV with direct-acting antivirals on reducing mortality related to extrahepatic manifestations: a large population-based study in British Columbia, Canada.
Jeong D, Wong S, Karim ME, Manges AR, Makuza JD, Bartlett SR, Velásquez García HA, Luster D, Adu PA, Binka M, Yu A, Krajden M, Janjua NZ. Jeong D, et al. Among authors: janjua nz. Lancet Reg Health Am. 2023 Dec 29;29:100658. doi: 10.1016/j.lana.2023.100658. eCollection 2024 Jan. Lancet Reg Health Am. 2023. PMID: 38235369 Free PMC article.
COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals.
Faksova K, Walsh D, Jiang Y, Griffin J, Phillips A, Gentile A, Kwong JC, Macartney K, Naus M, Grange Z, Escolano S, Sepulveda G, Shetty A, Pillsbury A, Sullivan C, Naveed Z, Janjua NZ, Giglio N, Perälä J, Nasreen S, Gidding H, Hovi P, Vo T, Cui F, Deng L, Cullen L, Artama M, Lu H, Clothier HJ, Batty K, Paynter J, Petousis-Harris H, Buttery J, Black S, Hviid A. Faksova K, et al. Among authors: janjua nz. Vaccine. 2024 Apr 2;42(9):2200-2211. doi: 10.1016/j.vaccine.2024.01.100. Epub 2024 Feb 12. Vaccine. 2024. PMID: 38350768 Free article.
A multiprovincial retrospective analysis of the incidence of myocarditis or pericarditis after mRNA vaccination compared to the incidence after SARS-CoV-2 infection.
Naveed Z, Chu C, Tadrous M, Veroniki AA, Li J, Rouleau I, Febriani Y, Calzavara A, Buchan SA, Nasreen S, Schwartz KL, Wilton J, Seo CY, Thampi N, Wilson SE, Naus M, De Serres G, Janjua NZ, Kwong JC; Canadian Immunization Research Network (CIRN) Provincial Collaborative Network investigators. Naveed Z, et al. Among authors: janjua nz. Heliyon. 2024 Feb 19;10(5):e26551. doi: 10.1016/j.heliyon.2024.e26551. eCollection 2024 Mar 15. Heliyon. 2024. PMID: 38439866 Free PMC article.
Cohort profile: the British Columbia COVID-19 Cohort (BCC19C)-a dynamic, linked population-based cohort.
Wilton J, Abdulmenan J, Chong M, Becerra A, Najmul Hussain M, Harrigan SP, Velásquez García HA, Naveed Z, Sbihi H, Smolina K, Taylor M, Adhikari B, Zandy M, Setayeshgar S, Li J, Abdia Y, Binka M, Rasali D, Rose C, Coss M, Flatt A, Mussavi Rizi SA, Janjua NZ. Wilton J, et al. Among authors: janjua nz. Front Public Health. 2024 Feb 21;12:1248905. doi: 10.3389/fpubh.2024.1248905. eCollection 2024. Front Public Health. 2024. PMID: 38450137 Free PMC article.
197 results